SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
15319241
Source:
http://linkedlifedata.com/resource/pubmed/id/15319241
Search
Subject
(
53
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0006142
,
umls-concept:C0013216
,
umls-concept:C0871261
,
umls-concept:C0872169
,
umls-concept:C1514307
,
umls-concept:C1521733
,
umls-concept:C1704632
,
umls-concept:C1706817
,
umls-concept:C2911692
pubmed:issue
9
pubmed:dateCreated
2004-8-20
pubmed:abstractText
The aim of this prospective study was to evaluate the predictive value of [18F]fluorodeoxyglucose positron emission tomography (FDG PET) for the pathological response of breast cancer after completion of neo-adjuvant chemotherapy.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9007735
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Fluorodeoxyglucose F18
,
http://linkedlifedata.com/resource/pubmed/chemical/Radiopharmaceuticals
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0923-7534
pubmed:author
pubmed-author:IRAG HGHJr
,
pubmed-author:KatzR VRV
,
pubmed-author:KimS-kSK
,
pubmed-author:LeeE SES
,
pubmed-author:SOKK
pubmed:issnType
Print
pubmed:volume
15
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1352-7
pubmed:meshHeading
pubmed-meshheading:15319241-Adult
,
pubmed-meshheading:15319241-Aged
,
pubmed-meshheading:15319241-Biopsy
,
pubmed-meshheading:15319241-Breast
,
pubmed-meshheading:15319241-Breast Neoplasms
,
pubmed-meshheading:15319241-Female
,
pubmed-meshheading:15319241-Fluorodeoxyglucose F18
,
pubmed-meshheading:15319241-Humans
,
pubmed-meshheading:15319241-Logistic Models
,
pubmed-meshheading:15319241-Middle Aged
,
pubmed-meshheading:15319241-Neoadjuvant Therapy
,
pubmed-meshheading:15319241-Neoplasm Staging
,
pubmed-meshheading:15319241-Positron-Emission Tomography
,
pubmed-meshheading:15319241-Predictive Value of Tests
,
pubmed-meshheading:15319241-Prognosis
,
pubmed-meshheading:15319241-Prospective Studies
,
pubmed-meshheading:15319241-Radiopharmaceuticals
,
pubmed-meshheading:15319241-Treatment Outcome
pubmed:year
2004
pubmed:articleTitle
Predictive value of [18F]FDG PET for pathological response of breast cancer to neo-adjuvant chemotherapy.
pubmed:affiliation
Research Institute, National Cancer Center, Goyang, Gyeonggi, Republic of Korea. growthkim@daum.net
pubmed:publicationType
Journal Article